"Characterization of glucagon-like peptide-1 receptor-binding determinants"
Through tailored nutrition strategies and individualized fitness guidance, we empower patients to achieve balanced, lasting results
Endocrinology 166:bqaf028 Kaur M, Misra S (2024) A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
What medical conditions might prevent me from using Ozempic
The architecture follows the same long-acting lipopeptide design language as tirzepatide (a chimeric backbone, non-natural amino acid substitutions for protease resistance, a fatty acid modification on a lysine side chain to drive albumin binding) but the receptor-recognition surfaces are tuned to add glucagon-receptor agonism on top of the GIP and GLP-1 dual coverage that tirzepatide provides
This combined action helps maintain stable blood sugar levels [3, 4]